HK40078570B - 用於预防1型糖尿病的方法和组合物 - Google Patents

用於预防1型糖尿病的方法和组合物

Info

Publication number
HK40078570B
HK40078570B HK62023068164.0A HK62023068164A HK40078570B HK 40078570 B HK40078570 B HK 40078570B HK 62023068164 A HK62023068164 A HK 62023068164A HK 40078570 B HK40078570 B HK 40078570B
Authority
HK
Hong Kong
Prior art keywords
composition
diabetes
type
insulin
subject
Prior art date
Application number
HK62023068164.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK40078570A (zh
Inventor
Mary S. MORRIS
Original Assignee
Dr. Mary Morris & Associates, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Mary Morris & Associates, Llc filed Critical Dr. Mary Morris & Associates, Llc
Publication of HK40078570A publication Critical patent/HK40078570A/zh
Publication of HK40078570B publication Critical patent/HK40078570B/zh

Links

HK62023068164.0A 2019-12-06 2020-11-25 用於预防1型糖尿病的方法和组合物 HK40078570B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/944,503 2019-12-06

Publications (2)

Publication Number Publication Date
HK40078570A HK40078570A (zh) 2023-03-31
HK40078570B true HK40078570B (zh) 2025-12-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP1928499B1 (en) Use of a dpp-iv inhibitor to reduce hypoglycemic events
US8481490B2 (en) Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis
CA2518216C (en) Oral insulin therapies and protocol
Kikuchi et al. Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus
TWI459962B (zh) 包含胰島素、菸鹼醯胺及胺基酸的製劑
US8962554B2 (en) Oral insulin therapies and protocol
US20180161400A1 (en) Antidiabetic oral insulin biguanide combination
KR20180095100A (ko) 약제학적 조성물, 치료 방법 및 이의 용도
EP4069278B1 (en) Methods and compositions for the prevention of type 1 diabetes
EP4487909A2 (en) Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
Waickus et al. Recognizing factitious hypoglycemia in the family practice setting
Suprapti et al. REVIEW OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS AMBULATORY PATIENTS.
AU2021356578A1 (en) Methods and compositions for the treatment and prevention of type 1 diabetes
HK40078570A (zh) 用於预防1型糖尿病的方法和组合物
HK40078570B (zh) 用於预防1型糖尿病的方法和组合物
Cryer Hypoglycemia of obscure cause
Tatar The role of hepatitis C virus genotypes in development of autoimmune diseases
Shifteh An Analysis of Different Treatment Options for Type 1 Diabetes Mellitus
US20220153803A1 (en) Modified glucagon molecues and formulations with oxidation resistance and methods and kits of employing the same
Ohneda Effect of Glicentin-Related Peptides on Endocrine Function of Pancreas in Dogs¹
Herring Insulin Detemir Compared to NPH insulin: A Study to Explore whether Differences Exist between Glucose Flux, Lipolysis, Pharmacokinetics and Brain Function during Hyperglycaemia in Type 1 Diabetes